Correlates of increased lean muscle mass in women with polycystic ovary syndrome

European Journal of Endocrinology

Volumn 161, Issue 4, 2009, Pages 583-589

  Carmina, E ^a   Guastella, E ^a   Longo, R A ^a   Rini, G B ^a   Lobo, R A ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; HORMONE BINDING PROTEIN; INSULIN; TESTOSTERONE;

ADULT; AGE DISTRIBUTION; ANDROGEN BLOOD LEVEL; ARTERIAL WALL THICKNESS; ARTICLE; BODY FAT DISTRIBUTION; BONE DENSITY; BONE MASS; CAROTID ARTERY; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CORRELATIONAL STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FREE ANDROGEN INDEX; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LEAN MUSCLE MASS; MAJOR CLINICAL STUDY; MUSCLE MASS; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; TESTOSTERONE BLOOD LEVEL; ADOLESCENT; BLOOD; BODY COMPOSITION; BODY MASS; BODY WEIGHT; ECHOGRAPHY; HISTOLOGY; MALE; METABOLISM; OVULATION; PATHOLOGY; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; SKELETAL MUSCLE; WAIST HIP RATIO;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; ADULT; ANDROGENS; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; CAROTID ARTERIES; FEMALE; HUMANS; INSULIN; MALE; MUSCLE, SKELETAL; OVULATION; POLYCYSTIC OVARY SYNDROME; TESTOSTERONE; WAIST-HIP RATIO; YOUNG ADULT;

EID: 70349760151     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0398     Document Type: Article

References (39)

1. Puder JJ, Varga S, Kraenzlin M, De Geyter C, Keller U & Muller B. Central fat excess in polycystic ovary syndrome: relation to low grade inflammation and insulin resistance. Journal of Clinical Endocrinology and Metabolism 2005 90 6014-6021. (Pubitemid 41606519)
2. Carmina E, Bucchieri S, Esposito A, Del Puente A, Mansueto P, Di Fede G & Rini GB. Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. Journal of Clinical Endocrinology and Metabolism 2007 92 2500-2505. (Pubitemid 47037349)
3. Barber TM, Golding SJ, Alvey C, Wass JA, Karpe F, Franks S & McCarthy MI. Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2008 93 999-1004.
4. Lord J, Thomas R, Fox B, Acharya U & Wilkin T. The central issue? Visceral fat is a good marker of insulin resistance and metabolic disturbances in women with polycystic ovary syndrome British Journal of Obstetrics and Gynaecology 2006 113 1203-1209.
5. Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R & Poehlman ET. Metabolic and body composition factors in subgroups of obesity: what do we know? Journal of Clinical Endocrinology and Metabolism 2004 89 2569-2575.
6. Forbes GB. Longitudinal changes in adult fat-free mass: influence of body weight. American Journal of Clinical Nutrition 1999 70 1025-1031.
7. Douchi T, Oki T, Yamasaki H, Kuwahata R, Nakae M & Nagata Y. Relationship of androgens to muscle size and bone mineral density in women with polycystic ovary syndrome. Obstetrics and Gynecology 2001 98 445-449. (Pubitemid 32889578)
8. Notelovitz M. Androgen effects on bone and muscle. Fertility and Sterility 2002 4 534-541.
9. Kirchengaast S & Huber J. Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Human Reproduction 2001 16 1255-1260. (Pubitemid 32544700)
10. Ibanez L & De Zegher F. Ethynilestradiol-drospirenone, flutamide- metformin or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity. Journal of Clinical Endocrinology and Metabolism 2004 89 1592-1597. (Pubitemid 38507907)
11. Carmina E, Legro RS, Stamets K, Lowell J & Lobo RA. Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet. Human Reproduction 2003 11 2289-2293.
12. Essah P, Nestler JE & Carmina E. Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome. Journal of Endocrinological Investigation 2008 31 35-41.
13. Corbould A, Zhao H, Mirzoeva S, Aird D & Dunaif A. Enhanced mitogenic signaling in skeletal muscle in women with polycystic ovary syndrome. Diabetes 2006 51 751-759. (Pubitemid 43343232)
14. Bots ML, Hofman A & Grobbee DE. Increased common carotid intima-media thickness. Adaptive response or a reflection of atherosclerosis? Findings from the Rotterdam study. Stroke 1997 28 2442-2447.
15. Kozakowa M, Palombo C, Paterni M, Anderwald CH, Konrad T, Colgan MP, Flyvbjerg A & Dekker J. Body composition and common carotid artery remodeling in a healthy population. Journal of Clinical Endocrinology and Metabolism 2008 93 3325-3332.
16. Orio F Jr, Palomba S, Spinelli L, Cascella T, Tauchmanova L, Zullo F, Lombardi G & Colao A. The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study. Journal of Clinical Endocrinology and Metabolism 2004 89 3696-3701. (Pubitemid 39071458)
17. Orio F Jr, Palomba S, Cascella T, De Simone B, Di Biase S, Russo T, Labella D, Zullo F, Lombardi G & Colao A. Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2004 89 4588-4593. (Pubitemid 39244474)
18. Carmina E, Orio F, Palomba S, Longo RA, Cascella T, Colao A, Lombardi G, Rini GB & Lobo A. Endothelial dysfunction in PCOS: role of obesity and adipose hormones. American Journal of Medicine 2006 119 356.e1-356.e6.
19. Crouse JR III, Craven TE, Hagaman AP & Bond MG. Association of coronary disease with segment-specific intimal-medial thickening of the extracranial carotid artery. Circulation 1995 92 1141-1147.
20. Orio F Jr, Palomba S, Cascella T, De Simone B, Manguso F, Savastano S, Russo T, Tolino A, Zullo F, Lombardi G, Azziz R & Colao A. Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study. Journal of Clinical Endocrinology and Metabolism 2005 90 6072-6076. (Pubitemid 41606527)
21. Ubels FL, Terpstra WF & Smith AJ. Carotid intima-media thickness: influence of treatment and clinical implications. Netherlands Journal of Medicine 1999 55 188-195.
22. Strauss BJ, Gibson PR, Stroud DB, Borovnicar DJ, Xiong DW & Keogh J. Total body dual X-ray absorptiometry is a good measure of both fat mass and fat free mass in liver cirrhosis compared to "gold standard" techniques. Melbourne liver group. Annals of the New York Academy of Sciences 2000 904 55-62.
23. Miller A, Strauss BJ, Mol S, Kyoonq A, Holmes PH, Finlay P, Bardin PG & Guy P. Dual energy X-ray absorptiometry is the method of choice to assess body composition in COPD. Radiology 2009 14 411-418.
24. Andreoli A, Scalzo G, Masala S, Tarantino U & Guglielmi G. Body composition assessment by dual energy X-ray absorptiometry. La Radiologia Medica 2009 114 286-300.
25. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar- Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE & Witchel SF. Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. Journal of Clinical Endocrinology and Metabolism 2006 91 4237-4245. (Pubitemid 44833391)
26. Carmina E, Rosato F, Jannì A, Rizzo M & Longo RA. Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. Journal of Clinical Endocrinology and Metabolism 2006 91 2-6. (Pubitemid 43069106)
27. Salonen JT & Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arteriosclerosis, Thrombosis, and Vascular Biology 1991 11 1245-1249.
28. Gamble G, Beaumont B, Smith H, Zorn J, Sanders G, Merrilees J, MacMahon S & Sharpe N. B-mode ultrasound images of the carotid artery wall: correlation of ultrasound with histological measurements. Atherosclerosis 1993 102 163-173. (Pubitemid 23283951)
29. Roman MJ, Naqvi TZ, Gardin JM, Gerhard-Herman M, Jaff M & Mohler E. American society of echocardiography report. Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the American Society of Echocardiography and the Society for Vascular Medicine and Biology. Vascular Medicine 2006 11 201-211.
30. Simon A, Chironi J & Levenson J. Comparative performance of subclinical atherosclerosis tests in predicting coronary heart disease in asymptomatic individuals. European Heart Journal 2007 28 2967-2971. (Pubitemid 350262263)
31. Bots ML, Hoes AW, Koudstaal PJ, Hofman A & Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation 1997 96 1432-1437. (Pubitemid 27375333)
32. Howard G, Sharrett AR, Heiss G, Evans GW, Chambless LE, Riley WA & Burke GL. Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. Stroke 1993 24 1297-1304. (Pubitemid 23254630)
33. Morley JE, Patrick P & Perry HM III. Evaluation of assays available to measure free testosterone. Metabolism 2002 51 554-559. (Pubitemid 34516507)
34. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G & Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method of assessing insulin sensitivity in humans. Journal of Clinical Endocrinology and Metabolism 2000 85 2402-2410. (Pubitemid 32269192)
35. Carmina E. Prevalence of idiopathic hirsutism. European Journal of Endocrinology 1998 139 424-427.
36. Glintborg D, Andersen M, Hagen C, Heickendorff L & Hermann AP. Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: a randomized, placebo controlled trial. Journal of Clinical Endocrinology and Metabolism 2008 93 1696-1701. (Pubitemid 351656507)
37. Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH & Jacobs HS. Mortality of woman with polycystic ovary syndrome at long term follow up. Journal of Clinical Epidemiology 1998 51 581-586. (Pubitemid 28376967)
38. Legro RS. Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocrine Reviews 2003 24 302-312.
39. Shaw LJ, Merz CN, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, Kelsey SF, Kip KE, Cooper-Dehoff RM, Johnson BD, Vaccarino V, Reis SE, Bittner V, Hodgson TK, Rogers W & Pepine CJ. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health National Heart, Lung, and Blood Institute (NHLBI) Sponsored Women's Ischemia Syndrome Evaluation (WISE). Journal of Clinical Endocrinology and Metabolism 2008 93 1276-1284.